Therapeutic Immunity? Plasma, Immunoglobulin Therapies Shield CSL From Global Financial Crisis

PERTH, Australia - Australian-headquartered CSL Limited has not been affected by the global financial crisis CEO Brian McNamee told analysts Feb. 18 during a half-year earnings call. Australia's financial year begins July 1 and ends June 30